Literature DB >> 11037182

Subacute myelo-optico-neuropathy: clioquinol intoxication in humans and animals.

J Tateishi1.   

Abstract

It remains a tragic event that some 10,000 individuals in Japan developed a unique neurologic disease, subacute myelo-optico-neuropathy (SMON). Many of the affected patients still suffer serious sequelae, such as dysesthesia and muscle weakness in the lower extremities, and loss or deficits in visual acuity. Neuropathologic studies on SMON patients and experimental reproduction of the disease in animals which had been administered clioquinol helped resolve the etiology of this disease. Common pathologic features seen in SMON patients and in dogs and cats chronically intoxicated with clioquinol were distal dominant axonopathy, mainly in the spinal long tracts and optic tracts. Particular abdominal symptoms present in patients after clioquinol ingestion could also be reproduced experimentally in dogs. SMON research in Japan may be worth reviewing for determining the etiology and preventing similar neurotoxic diseases in the future.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11037182     DOI: 10.1046/j.1440-1789.2000.00296.x

Source DB:  PubMed          Journal:  Neuropathology        ISSN: 0919-6544            Impact factor:   1.906


  21 in total

Review 1.  Clioquinol: review of its mechanisms of action and clinical uses in neurodegenerative disorders.

Authors:  Silvio R Bareggi; Umberto Cornelli
Journal:  CNS Neurosci Ther       Date:  2010-12-27       Impact factor: 5.243

Review 2.  The development of anti-amyloid therapy for Alzheimer's disease : from secretase modulators to polymerisation inhibitors.

Authors:  Paul S Aisen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

3.  Optic neuropathy in a herd of beef cattle in Alberta associated with consumption of moldy corn.

Authors:  Lynne S Sandmeyer; Vladimir Vujanovic; Lyall Petrie; John R Campbell; Bianca S Bauer; Andrew L Allen; Bruce H Grahn
Journal:  Can Vet J       Date:  2015-03       Impact factor: 1.008

4.  Combination treatment with fasudil and clioquinol produces synergistic anti-tumor effects in U87 glioblastoma cells by activating apoptosis and autophagy.

Authors:  Mingliang He; Ming Luo; Qingyu Liu; Jingkao Chen; Kaishu Li; Meiguang Zheng; Yinlun Weng; Leping Ouyang; Anmin Liu
Journal:  J Neurooncol       Date:  2016-01-02       Impact factor: 4.130

5.  Clioquinol inhibits dopamine-β-hydroxylase secretion and noradrenaline synthesis by affecting the redox status of ATOX1 and copper transport in human neuroblastoma SH-SY5Y cells.

Authors:  Masato Katsuyama; En Kimura; Masakazu Ibi; Kazumi Iwata; Misaki Matsumoto; Nozomi Asaoka; Chihiro Yabe-Nishimura
Journal:  Arch Toxicol       Date:  2020-10-09       Impact factor: 5.153

6.  Acute and bilateral blindness due to optic neuropathy associated with copper deficiency.

Authors:  Robert T Naismith; James B Shepherd; Conrad C Weihl; Nhial T Tutlam; Anne H Cross
Journal:  Arch Neurol       Date:  2009-08

Review 7.  Biometals and their therapeutic implications in Alzheimer's disease.

Authors:  Scott Ayton; Peng Lei; Ashley I Bush
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

8.  Clioquinol effects on tissue chelatable zinc in mice.

Authors:  Yuval B Nitzan; Israel Sekler; Christopher J Frederickson; Douglas A Coulter; Rengarajan V Balaji; Shu-Ling Liang; Ariel Margulis; Michal Hershfinkel; William F Silverman
Journal:  J Mol Med (Berl)       Date:  2003-08-19       Impact factor: 4.599

9.  Differential modulation of Alzheimer's disease amyloid beta-peptide accumulation by diverse classes of metal ligands.

Authors:  Aphrodite Caragounis; Tai Du; Gulay Filiz; Katrina M Laughton; Irene Volitakis; Robyn A Sharples; Robert A Cherny; Colin L Masters; Simon C Drew; Andrew F Hill; Qiao-Xin Li; Peter J Crouch; Kevin J Barnham; Anthony R White
Journal:  Biochem J       Date:  2007-11-01       Impact factor: 3.857

10.  Using zinc ion-enhanced fluorescence of sulfur quantum dots to improve the detection of the zinc(II)-binding antifungal drug clioquinol.

Authors:  Jie Zhao; Zhefeng Fan
Journal:  Mikrochim Acta       Date:  2019-12-03       Impact factor: 5.833

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.